Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings Routine +

Glow Lifetech Reports Record Q1 2026 Results; 35% YoY Revenue Growth, 27% Sequential Growth and Continued National Expansion Momentum

Record Revenue and Debt-Free Status Confirm Growth Trajectory Despite Stagnant Price Action

By The Northwire Desk — AI Analysis May 26, 2026 · 07:31 GLOW · 0.055 Glow LifeTech Corp.
Executive Summary
  • Q1 2026 Financial Performance: Reported record net revenue of $643,519, up 35% year-over-year (YoY) and 27% sequentially. Gross profit increased to $413,259 with a gross margin of 64%.
  • Profitability Improvement: EBITDA loss narrowed significantly from ($67,116) in Q1 2025 to only ($6,971) in Q1 2026. This represents a substantial reduction in operating losses.
  • Balance Sheet Strength: Cash balance increased by 44% to $1,590,927. Working capital surplus stands at $1,855,233 with a current ratio of 2.70x.
  • Capital Structure Cleanup: Eliminated 41,031,673 share purchase warrants and 5,025,000 stock options in Q1 2026. Remaining $0.07 warrants are noted to expire May 29, 2096 (data anomaly), expected to eliminate warrant overhang.
  • Commercial Expansion: Entered Canadian medical cannabis channel via Mendo Medical Cannabis platform. Expanded MOD™ and .decimal™ brands into Manitoba and New Brunswick. Added ~140 new retail locations in Ontario through partnerships with two large retailers.
  • Product Innovation: Launched MOD™ CBD Drops 1500 - 15 Pack in May 2026. Upcoming launch of .decimal™ Live Resin THC 10 - 50 Capsules scheduled for July 2026.
Material Impact
  • Confirmation of Guidance: The April 8, 2026 earnings release projected continued revenue and EBITDA growth for 2026. This Q1 report confirms that guidance is being met or exceeded, specifically regarding the narrowing loss trajectory.
  • EBITDA Trajectory: While the reduction in EBITDA loss from $67k to ~$7k is operationally significant, it remains a loss. The market has already priced in the debt-free status achieved in November 2025 and the positive cash flow trend starting Q3 2025.
  • Liquidity vs. Fundamentals: Despite strong fundamental improvements (debt-free, growing revenue, narrowing losses), the stock price has remained flat between $0.05 and $0.06 for over a year. This disconnect suggests low liquidity or market skepticism regarding sustainability rather than immediate material upside from this specific release alone.
  • Routine Nature: Quarterly earnings are expected events. The positive results align with previous strategic announcements (debt elimination, warrant reduction). Therefore, the news is incremental confirmation of an established trend rather than a sudden shock to the system.
GLOW · Price
Company Overview
  • Business Model: Manufacturer and distributor of cannabinoid-based products (CBD/THC) under brands MOD™ and .decimal™. Focus on oils, drops, and capsules for recreational and medical markets.
  • Flagship Projects: National expansion across Canadian provinces (Ontario, Saskatchewan, Manitoba, New Brunswick). Entry into the medical cannabis distribution channel via Mendo Medical Cannabis.
  • Market Position: MOD™ brand achieved #2 rank in Ontario oils category as of Q4 2025.
  • Development Stage: Commercial growth phase with established revenue streams and improving operational efficiency (EBITDA narrowing).
Read the original news release →

More from Glow LifeTech Corp.

Apr 30, 2026 · 07:31

Glow Lifetech Executes National Expansion Strategy Amidst Debt-Free Balance Sheet

Production / Operations Apr 08, 2026 · 07:31

Glow Lifetech posts record FY 2025 revenue, wipes out debt and trims warrant overhang – a turning point for the micro‑cap cannabis player

Earnings Mar 27, 2026 · 07:31

Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired

Financings Feb 03, 2026 · 07:31

Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy

Production / Operations Jan 07, 2026 · 07:31

Glow Lifetech Expands into Medical Cannabis Channel with National Launch on Mendo Medical

M&A / Property Nov 25, 2025 · 07:31

Glow Lifetech Reports Record Q3 2025 Financial Results; 193% YoY Revenue Growth and Achieves First Positive Cash Flow from Operations

Earnings